AIkido Pharma (NASDAQ:AIKI) Stock Price Passes Above 200-Day Moving Average of $2.23

AIkido Pharma Inc. (NASDAQ:AIKI)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.23 and traded as high as $3.00. AIkido Pharma shares last traded at $2.93, with a volume of 20,966 shares.

AIkido Pharma Price Performance

The stock has a market capitalization of $16.07 million, a PE ratio of -0.76 and a beta of 0.93. The company has a 50 day moving average price of $2.29 and a 200-day moving average price of $2.23.

Institutional Investors Weigh In On AIkido Pharma

Large investors have recently bought and sold shares of the stock. Jane Street Group LLC bought a new stake in AIkido Pharma in the third quarter valued at $77,000. Two Sigma Investments LP bought a new stake in AIkido Pharma in the third quarter worth approximately $367,000. Dimensional Fund Advisors LP lifted its position in shares of AIkido Pharma by 26.5% in the third quarter. Dimensional Fund Advisors LP now owns 57,849 shares of the business services provider’s stock valued at $396,000 after buying an additional 12,111 shares during the last quarter. Finally, Two Sigma Advisers LP grew its holdings in AIkido Pharma by 630.0% in the 3rd quarter. Two Sigma Advisers LP now owns 86,700 shares of the business services provider’s stock valued at $593,000 after buying an additional 74,824 shares in the last quarter. Hedge funds and other institutional investors own 10.88% of the company’s stock.

About AIkido Pharma

AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.